Cargando…

Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis

Detalles Bibliográficos
Autores principales:	Loffredo, Lorenzo, Di Castelnuovo, Augusto, Chiariello, Giovanni Alfonso, Pignatelli, Pasquale, Violi, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335104/ https://www.ncbi.nlm.nih.gov/pubmed/35354256 http://dx.doi.org/10.3324/haematol.2022.280652

Ejemplares similares

COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment?
por: Loffredo, Lorenzo, et al.
Publicado: (2020)

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis
por: Violi, Francesco, et al.
Publicado: (2020)

Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review
por: Violi, Francesco, et al.
Publicado: (2016)

Prophylactic Anticoagulation With Intermediate-Dose Certoparin in Vascular-Risk Pregnancies—The PACER-VARP Registry
por: Grünewald, Martin, et al.
Publicado: (2021)

The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2021)

Safety of Transesophageal Echocardiogram in Anticoagulated Patients
por: Natale, Francesco, et al.
Publicado: (2023)

Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
por: Bikdeli, Behnood, et al.
Publicado: (2020)

Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
por: Zhang, Sirui, et al.
Publicado: (2021)

Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007)

Moderate Weight Loss Decreases Oxidative Stress and Increases Antioxidant Status in Patients with Metabolic Syndrome
por: Del Ben, Maria, et al.
Publicado: (2012)

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease
por: Del Ben, Maria, et al.
Publicado: (2014)

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021)

Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19
por: Hoogenboom, Wouter S., et al.
Publicado: (2022)

Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study
por: Ageno, Walter, et al.
Publicado: (2021)

Vitamin E Serum Levels and Bleeding Risk in Patients Receiving Oral Anticoagulant Therapy: a Retrospective Cohort Study
por: Pastori, Daniele, et al.
Publicado: (2013)

The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2020)

Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study
por: Smadja, David M., et al.
Publicado: (2021)

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
por: Pastori, Daniele, et al.
Publicado: (2018)

SARS-CoV-2 and myocardial injury: a role for Nox2?
por: Violi, Francesco, et al.
Publicado: (2020)

Thrombosis in pre- and post-vaccination phase of COVID-19
por: Violi, Francesco, et al.
Publicado: (2021)

Reply to Chen and Vitetta
por: Violi, Francesco, et al.
Publicado: (2022)

Personalized prophylactic anticoagulation in hospitalized patients with Covid-19 – The role of anti-Xa monitoring
por: Kofteridis, Diamantis P., et al.
Publicado: (2021)

Prophylactic Anticoagulation in Nephrotic Syndrome
por: Gerstein, Jonathon, et al.
Publicado: (2023)

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis
por: Lee, Hyeon-Jeong, et al.
Publicado: (2023)

Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid
por: Kuno, Toshiki, et al.
Publicado: (2021)

Extra Virgin Olive Oil Reduces Gut Permeability and Metabolic Endotoxemia in Diabetic Patients
por: Bartimoccia, Simona, et al.
Publicado: (2022)

Relationship Between Platelet and Urinary 8‐Iso‐PGF2α Levels in Subjects With Different Degrees of NOX2 Regulation
por: Carnevale, Roberto, et al.
Publicado: (2013)

Dark Chocolate Acutely Improves Walking Autonomy in Patients With Peripheral Artery Disease
por: Loffredo, Lorenzo, et al.
Publicado: (2014)

Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms
por: Violi, Francesco, et al.
Publicado: (2016)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

Different rates of conjunctivitis in COVID-19 eastern and western hospitalized patients: a meta-analysis
por: Loffredo, Lorenzo, et al.
Publicado: (2021)

Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in Coronavirus Disease 2019
por: Motta, Jishu Kaul, et al.
Publicado: (2020)

Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach
por: Pastori, Daniele, et al.
Publicado: (2019)

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry
por: Pastori, Daniele, et al.
Publicado: (2019)

Upstream therapy with statin and recurrence of atrial fibrillation after electrical cardioversion. Review of the literature and meta-analysis
por: Loffredo, Lorenzo, et al.
Publicado: (2012)

Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia
por: Tacquard, Charles, et al.
Publicado: (2021)

High-Dose Prophylactic Anticoagulation for COVID-19 Pneumonia: A Review of Benefits and Risks
por: Kattakola, Yeshu, et al.
Publicado: (2023)

Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial
por: Labbe, Vincent, et al.
Publicado: (2022)

In elderly population prophylactic anticoagulation favors early detection of digestive track cancers: an observational study in eastern Poland
por: Szlendak, Malgorzata, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6vf9j8eccfln5vupv8r66lag1f